CervoMed CRVO
NASDAQ CRVO
$1.75 +0.38 (+28.10%)
As of: Nov 11, 2026 · 2:07 PM EST

CervoMed (CRVO) Return on Assets [ROA] (2009 - 2026)

Updated

CervoMed's Return on Assets [ROA] was -147.68% in Q2 2026, down 88.72 percentage points from -58.96% a year earlier but up 10.39 percentage points from the prior quarter.

Analysis

CervoMed (CRVO) Return on Assets [ROA] (2009 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at CervoMed came in at -81.74%, down 20.33 percentage points from FY2024.

  • Return on Assets [ROA] shows a five-year change of -27.01 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was -61.41% in FY2024 (+46.07 pp), -107.48% in FY2023 (-33.23 pp), -74.25% in FY2022 (-0.75 pp) and -73.50% in FY2021 (-18.77 pp).
  • Quarterly Return on Assets [ROA] has moved between -308.87% (Q1 2023) and -23.40% (Q3 2024) over five years.
  • Compared with a year earlier, Return on Assets [ROA] has declined for five straight quarters, with an average year-over-year change of -20.26 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q2 2024 (a gain of 227.31 percentage points); the worst was Q1 2023 (a drop of 242.76 percentage points).
  • Per Business Quant data, CRVO's Return on Assets [ROA] in the three quarters before Q2 2026 was -158.07% (Q1 2026), -100.80% (Q4 2025) and -74.47% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 CervoMed 20.73 Mn -57.60 Mn - -120.63%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -120.63%
Jun 30, 2026 -147.66%
Mar 31, 2026 -158.23%
Dec 31, 2025 -101.02%
Sep 30, 2025 -74.83%
Jun 30, 2025 -58.94%
Mar 31, 2025 -45.68%
Dec 31, 2024 -35.31%
Sep 30, 2024 -23.17%
Jun 30, 2024 -16.55%
Mar 31, 2024 -46.21%
Dec 31, 2023 -51.77%
Sep 30, 2023 150,414.20%
Jun 30, 2023 240,365.62%
Mar 31, 2023 216,753.31%
Dec 31, 2022 57,605.88%
Sep 30, 2022 64,099.07%
Jun 30, 2022 26,734.35%
Mar 31, 2022 23,495.47%
Dec 31, 2021 21,314.56%
API Access

CervoMed Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CRVO&period=max&api_key=YOUR_API_KEY